Eight patients had a poor effectiveness of bromocriptine treatment; of these, two patients had an ideal reduction in PRL levels after treatment; however, their tumor size did not decrease significantly, and they still had clinical manifestations, such as headaches and vision loss, caused by tumor compression. This evidence concerns the gene PRL and neoplasm.